
Birth rates are plummeting worldwide - but it's not because people don't want kids anymore
More than half said financial factors such as affordable housing, childcare options and job security were things that had limited, or would limit, their ability to grow their families.
One in four said health issues were holding them back, while a fifth of respondents mentioned fears about global issues including climate change, wars and pandemics.
The findings come from a new survey of over 14,000 people by the United Nations Population Fund (UNFPA) - spanning 14 countries on five continents that are home to a third of the world's population.
Birth rates have been declining across almost all regions of the world, while life expectancy continues to grow.
There are concerns, from politicians and commentators like Elon Musk, that future generations of working age people will find it more difficult to economically support people of pension age as the ratio of workers to pensioners shifts.
"Vast numbers of people are unable to create the families they want," said Dr Natalia Kanem, executive director of the UNFPA.
"The issue is lack of choice, not desire, with major consequences for individuals and societies. That is the real fertility crisis, and the answer lies in responding to what people say they need: paid family leave, affordable fertility care, and supportive partners."
Differences around the world
The survey was carried out in four European countries, four in Asia, three across Africa and three from the Americas.
The countries were picked to try and represent "a wide variety of countries with different cultural contexts, fertility rates and policy approaches", according to the report's editor Dr Rebecca Zerzan.
It includes, for example, the country with the lowest fertility rate in the world - South Korea. It also includes country with a birth rate among the highest in the world, which also happens to be the most populous country in its continent - Nigeria.
The others, in order of population size, are India, the US, Indonesia, Brazil, Mexico, Germany, Thailand, South Africa, Italy, Morocco, Sweden and Hungary.
In many cases there were significant differences in responses depending on which country people were reporting from.
For example in Nigeria, a third of men (although only 21% of women) reported that they wanted to have four or more children. The numbers were similar in South Africa. However in South Korea, Thailand, Italy, Germany and Hungary, no more than 5% agreed.
Fertility issues were twice as likely in the US (16% of respondents) as in neighbouring Mexico (8%).
In South Korea, three in five respondents reported financial limitations as an obstacle.
But in Sweden, where both men and women are entitled to 480 days of paid parental leave per child (which can also be transferred to grandparents), fewer than one in five said the same.
Birth rates in Sweden are still among the lowest in the world, however. Dr Zerzan told Sky News that this shows that no one factor alone contributes to people feeling empowered to have children at the right time.
"A third of people in Sweden say they think raising a child will take up too much time and energy. And a higher number of people there, compared with other countries, are also concerned about climate change and bringing a child in to an uncertain world."
Unintended pregnancies vs not as many children as wanted
A curious finding from the survey is that, while there has been much discussion around declining fertility rates, almost a third of people said they or their partner had experienced an unintended pregnancy.
Globally, as people who become pregnant unintentionally often do so more than once, half of all pregnancies are unintended.
In Morocco and South Africa, around half of people had experience of an unintended pregnancy. In the same two countries, more than half of people had experience of being unable to have a child at their preferred time.
Overall, one in eight people had experienced both an unintended pregnancy and barriers to a desired child.
"Everywhere we look, people are struggling to freely realise their reproductive aspirations," explains the report.
People who had more children than they wanted, and people who had fewer, were present in countries with high and low fertility rates.
"That indicates that barriers to achieving one's ideal family are ubiquitous."
What can be done to help?
The report says that the crisis does require political interventions, but warns against policies that often amount to short-term fixes, or those designed to coerce people to either use or not use contraception.
"Whether the policies are coercive or not, there are real risks to treating fertility rates as a faucet to be turned on or off. Many of the countries that are today seeking to increase fertility have, within the last 40 years, sought to decrease birth rates.
"For example, China, Japan, the Republic of Korea, Thailand and Türkiye all reported in 1986 an intention to lower their national fertility rates through policy interventions, deeming their respective fertility rates at that time as 'too high'. By 2015, however, all five countries had switched to policies designed to boost fertility.
"Today all five have total fertility rates below two children per woman."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
7 hours ago
- Daily Mail
Pharma industry latest to be hit by layoffs as giant announces sweeping jobs cull
Moderna is set to slash ten percent of its workforce this year, the pharmaceutical giant revealed on Thursday morning. The company - the maker of one of the most prevalent Covid-19 vaccines - now faces uncertainty as that market dwindles. The move, announced in an internal memo by CEO Stephane Bancel, is part of the company's previous plan to cut operating expenses by about $1.5 billion by 2027. 'We've made significant progress by scaling down R&D as respiratory trials conclude, renegotiating supplier agreements, and reducing manufacturing costs,' Bancel said in the memo. Moderna has been banking on revenue from newer mRNA shots, including its experimental COVID-flu combination vaccine, to make up for falling sales of its COVID-19 shot and less-than-expected uptake of its respiratory syncytial virus vaccine. However, investors have been concerned about the prospects of new shots and the changes in vaccine policy under U.S. Health Secretary and vaccine skeptic Robert F. Kennedy Jr. Moderna said in May that it did not expect regulatory approval for its combination shot until 2026, since the U.S. Food and Drug Administration asked for late-stage data showing the vaccine's efficacy against the flu. The company had previously hoped to launch the vaccine for the autumn respiratory disease season in 2025 or 2026. Its shares, down around 23 percent so far this year, have been battered by mounting challenges and declining COVID revenue. Moderna's shares have lost more than 90 percent of their value from its pandemic-era highs.


Daily Mail
11 hours ago
- Daily Mail
Elon Musk's brain chip company Neuralink to test implants in UK
Elon Musk 's brain implant company will launch a clinical study in Britain to test how its chips can allow severely paralysed patients to control everyday items with their thoughts. Neuralink is partnering with University College London Hospitals Trust and Newcastle Hospitals for the project, it said today. Those living with paralysis due to conditions such as spinal cord injuries and a nervous system disease called amyotrophic lateral sclerosis qualify for the study, the company revealed in a post on X. The firm began human trials on its brain implant last year after resolving safety concerns flagged by the US Food and Drug Administration. Five patients around the world with severe paralysis are using its device, according to Neuralink. They include a woman who has been paralysed for 20 years and has now regained the ability to use a computer. Audrey Crews, from Louisiana, revealed on X last month how she was now able to write her name on a computer screen thanks to Neuralink's implant. 'I tried writing my name for the first time in 20 years. I'm working on it,' Ms Crews posted during her first signature attempt since 2005. She was severely injured in a car accident aged 16, damaging two vertebrae in her neck and leaving her with no feeling in her arms and legs. Mr Musk, the CEO of SpaceX and Tesla, co-founded Neuralink in 2016 with a group of neuroscience, engineering, and robotics experts. Their goal was to merge human intelligence with artificial intelligence, treat brain disorders and potentially enhance human capabilities. The billionaire said in June that the chip technology had made 'an incredible amount of progress'. But he emphasised the company's cautious approach, adding: 'The reason we're not moving faster than we are is because we're taking great care with each individual to make sure we never miss - and, so far, we haven't.'


Telegraph
11 hours ago
- Telegraph
British patients to get Musk's Neuralink brain chip implants
British patients are to be implanted with Elon Musk's Neuralink brain chip in an attempt to allow paralysed people to control a smartphone with their thoughts. Mr Musk's start-up, which has already conducted tests in the US, said it was launching a clinical study in the UK with University College London Hospitals and Newcastle upon Tyne Hospitals NHS Foundation Trust after getting the green light from UK medical regulators. The trial will recruit seven patients whose movement is severely impaired from spinal cord injuries or neurological conditions, installing Neuralink's chip under their skull to communicate with a smartphone or tablet. The company's N1 chip – a so-called Brain-Computer Interface (BCI) – is about the size of a 10p coin and connects to the human brain with 128 threads that are thinner than a human hair. These threads connect 1,000 electrodes to the human brain that can read electrical signals generated by neural activity, turning these waves into keyboard strokes or cursor movements. Neuralink said: 'The launch of this study in Great Britain builds upon the successes of our trials in the US and marks an important step towards bringing our life-changing BCI technology to individuals with neurological disorders around the world.' Last year, Noland Arbaugh, from Arizona, became the first human to be implanted with Neuralink's brain chip. He has since demonstrated how the chip allows him to control a computer and play complicated video games. After his operation, however, around 85pc of the threads from his Neuralink chip lost their connection to his brain. The company was able to maintain a high level of performance using software updates to improve how the chip read his brain signals. While Neuralink is initially aimed at patients with serious health conditions, Mr Musk has long claimed that its chips could ultimately lead to a kind of human-AI 'symbiosis', boosting the brain power of otherwise healthy humans. He said on a podcast he expected hundreds of millions of people to have brain-chips installed, claiming it would give people 'superhuman abilities', allow them to 'upload your memories' or cure blindness. Neuralink has already begun work on trials in Canada and the UAE, although the UK is the first country in Europe to launch a study of the technology. It has been approved by the Medicines and Healthcare products Regulatory Agency. University College London said Neuralink's technology had the 'potential to transform the lives of individuals with neurological disorders around the world'. The operations will be undertaken using Neuralink's R1 surgical robot. Professor Harith Akram, a consultant neurosurgeon at the hospital, said the launch of the study 'represents a major milestone in the development of brain-computer interface technology, with the potential to transform the lives of people living with severe neurological disorders worldwide'. William Muirhead, a consultant neurosurgeon at the National Hospital for Neurology, said: 'This study reflects our commitment to pioneering therapies that restore function, independence, and communication in patients with profound neurological disability.'